ES2002004A6 - Procedimiento para llevar a cabo el analisis inmunoquimico de lipoproteinas y-o apolipoproteinas - Google Patents

Procedimiento para llevar a cabo el analisis inmunoquimico de lipoproteinas y-o apolipoproteinas

Info

Publication number
ES2002004A6
ES2002004A6 ES8602242A ES8602242A ES2002004A6 ES 2002004 A6 ES2002004 A6 ES 2002004A6 ES 8602242 A ES8602242 A ES 8602242A ES 8602242 A ES8602242 A ES 8602242A ES 2002004 A6 ES2002004 A6 ES 2002004A6
Authority
ES
Spain
Prior art keywords
apolipoproteins
lipoproteins
carrying
methods
denaturing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES8602242A
Other languages
English (en)
Inventor
Gunnel Birgitta Jonsson
Sture Erling Holmlund
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Health AB
Original Assignee
Pharmacia AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia AB filed Critical Pharmacia AB
Publication of ES2002004A6 publication Critical patent/ES2002004A6/es
Expired legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/92—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving lipids, e.g. cholesterol, lipoproteins, or their receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/04—Endocrine or metabolic disorders
    • G01N2800/044—Hyperlipemia or hypolipemia, e.g. dyslipidaemia, obesity
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/804—Radioisotope, e.g. radioimmunoassay
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/815—Test for named compound or class of compounds
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/825—Pretreatment for removal of interfering factors from sample

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Endocrinology (AREA)
  • Cell Biology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)

Abstract

UN PROCEDIMIENTO PARA LLEVAR A CABO ANALISIS INMUNOQUIMICOS DE LIPOPROTEINAS Y/O APOLIPOPROTEINAS, DONDE, CON ANTERIORIDAD A LA REACCION DE LA MUESTRA CON EL ANTICUERPO ANTI(APOLIPOPROTEINA) O ANTI(LIPOPROTEINA) ADECUADO, EL PH DE LA MUESTRA SE MANTIENE EN UN VALOR NO DESNATURALIZANTE EN UNA ETAPA DE PRETRATAMIENTO PARA LA EXPOSICION DE LOS DETERMINANTES ANTIGENICOS, ENCONTRANDOSE DICHO VALOR NO DESNATURALIZANTE POR ENCIMA DE PH 9 O POR DEBAJO DE PH 3. DESPUES DE LA ETAPA DE PRETRATAMIENTO, EL PH SE AJUSTA PARA LA INMUNO-REACCION, DE MANERA QUE PUEDA REALIZARSE ENTONCES EL ANALISIS INMUNOQUIMICO DE MANERA CONOCIDA PER SE.
ES8602242A 1985-09-27 1986-09-26 Procedimiento para llevar a cabo el analisis inmunoquimico de lipoproteinas y-o apolipoproteinas Expired ES2002004A6 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE8504466A SE448324B (sv) 1985-09-27 1985-09-27 Sett vid immunkemisk bestemning av lipoproteiner och apolipoproteiner

Publications (1)

Publication Number Publication Date
ES2002004A6 true ES2002004A6 (es) 1988-07-01

Family

ID=20361533

Family Applications (1)

Application Number Title Priority Date Filing Date
ES8602242A Expired ES2002004A6 (es) 1985-09-27 1986-09-26 Procedimiento para llevar a cabo el analisis inmunoquimico de lipoproteinas y-o apolipoproteinas

Country Status (9)

Country Link
US (1) US4877746A (es)
EP (1) EP0238614B1 (es)
JP (1) JPS63501037A (es)
AU (1) AU590340B2 (es)
CA (1) CA1280070C (es)
DE (1) DE3675763D1 (es)
ES (1) ES2002004A6 (es)
SE (1) SE448324B (es)
WO (1) WO1987002137A1 (es)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2627589B1 (fr) * 1988-02-24 1995-06-09 Pasteur Institut Procede immunoenzymometrique selectif pour le dosage de lipoproteines contenant de l'apob ou un fragment de celle-ci, anticorps monoclonaux anti-lp(a) et application au diagnostic de l'atherosclerose
JPH02242158A (ja) * 1989-03-15 1990-09-26 Nippon Shoji Kk ヒトアポリポ蛋白ｃ―３の測定法
US5473039A (en) * 1989-08-18 1995-12-05 The Scripps Research Institute Polypeptide analogs of apolipoprotein E, diagnostic systems and methods using the analogs
US5168045A (en) * 1989-08-18 1992-12-01 The Scripps Research Institute Diagnostic systems and methods using polypeptide analogs of apolipoprotein e
US5262303A (en) * 1989-10-13 1993-11-16 Trustees Of Boston University Ligand/anti-ligand assays for adherent proteins
US5149501A (en) * 1990-01-29 1992-09-22 Cirrus Diagnostics, Inc. Multichambered container and instrument for performing diagnostic tests
CA2052316C (en) * 1990-10-10 1997-12-23 Edward A. Oakley Sludge flow measuring system
WO1992009893A1 (en) * 1990-11-29 1992-06-11 Carbaugh John E DIAGNOSTIC AND THERAPEUTIC COMPOSITIONS AND METHODS FOR LIPOPROTEIN(a)
EP0559795B1 (en) * 1990-11-30 1995-12-27 Monoclonetics International, Inc. Methods for the diagnosis of chronic lower back and cervical pain
US5844097A (en) * 1990-11-30 1998-12-01 Monoclonetics International, Inc. Methods for the diagnosis of peripheral nerve damage
ATE183312T1 (de) * 1991-05-23 1999-08-15 Leo J Seman Jr Verfahren zur reinigung und detektion von lipoprotein (a) und assoziiertem cholesterol
AU672028B2 (en) * 1992-08-14 1996-09-19 Shino-Test Corporation Peptides containing respective amino acid sequences selected from among those of lipoprotein(a) and apolipoprotein(a), antibodies respectively recognizing these amino acid sequences, and method of assaying with these antibodies
CA2172247A1 (en) * 1993-09-29 1995-04-06 Eiji Matsuura Method of assaying oxidized lipoprotein and application thereof
GB0001089D0 (en) * 2000-01-18 2000-03-08 Council Cent Lab Res Councils Lipoprotein assay
ES2252358T3 (es) 2002-04-09 2006-05-16 Cholestech Corporation Metodo y dispositivo de ensayo para la cuantificacion del colesterol asociado a lipoproteinas de alta densidad.
JP3600231B1 (ja) * 2003-09-30 2004-12-15 森永製菓株式会社 イムノアッセイ
WO2008086019A1 (en) 2007-01-09 2008-07-17 Cholestech Corporation Device and method for measuring ldl-associated cholesterol

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2829531A1 (de) * 1978-07-05 1980-01-24 Heuck Claus Christian Dr Rer N Verfahren zur quantitativen bestimmung eines serumproteins in getruebten serum- und plasma-proben
JPS58166263A (ja) * 1982-03-27 1983-10-01 Dai Ichi Pure Chem Co Ltd アポ蛋白ａ−ｉ標準品の調製法
DE3323949A1 (de) * 1983-07-02 1985-01-03 Boehringer Mannheim Gmbh, 6800 Mannheim Verfahren und mittel zur raschen und vollstaendigen beseitigung einer truebung in einer biologischen fluessigkeit
JPS6015559A (ja) * 1983-07-06 1985-01-26 Shiraimatsu Shinyaku Kk アポリポ蛋白−ｂの酵素免疫測定試薬
DE3338836A1 (de) * 1983-10-26 1985-05-09 Boehringer Mannheim Gmbh Verfahren zur bestimmung der low density lipoproteine (ldl) und reagenz zu seiner durchfuehrung
DE3533288A1 (de) * 1985-09-18 1987-03-26 Boehringer Mannheim Gmbh Verfahren und reagenz zur spezifischen bestimmung von hdl-cholesterin im serum

Also Published As

Publication number Publication date
EP0238614B1 (en) 1990-11-22
AU590340B2 (en) 1989-11-02
SE448324B (sv) 1987-02-09
WO1987002137A1 (en) 1987-04-09
AU6403986A (en) 1987-04-24
CA1280070C (en) 1991-02-12
JPS63501037A (ja) 1988-04-14
DE3675763D1 (de) 1991-01-03
SE8504466D0 (sv) 1985-09-27
US4877746A (en) 1989-10-31
EP0238614A1 (en) 1987-09-30

Similar Documents

Publication Publication Date Title
ES2002004A6 (es) Procedimiento para llevar a cabo el analisis inmunoquimico de lipoproteinas y-o apolipoproteinas
SE8102558L (sv) Immunologisk bestemmningsmetod
DE3379116D1 (en) Immunoassay method
DE2963773D1 (en) Immunological determination process
EP0232717A3 (en) Antibody specific to low-molecular weight substance and method of producing the same by using colloidal metal particles as carrier
DE58902586D1 (de) Immunoassay und -rolymere igg-derivate zur kompensation von stoerfaktoren in immunoassays.
IL55816A0 (en) Method for simultanesous immunoassay of several different antibodies
DE3879000D1 (de) Immunoassaymethode zum auffinden von antikoerpern zu antigenen.
DE69115267D1 (de) Antigen-/antiantigenspaltung.
DE3169833D1 (en) Process for performing analytical determinations by means of the chemiluminescent method, and application of this process to immuno assays
ATE42836T1 (de) Verfahren und reagenz zur quantitativen bestimmung von freiem thyroxin in plasma, serum oder vollblut.
PT84504A (en) Method for the detection of haptens in immunoassay techniques
EP0161107A3 (en) Immunometric method for the determination of a hapten
EP0245509A4 (en) IMMUNOANALYSIS PROCEDURE.
GR3005066T3 (es)
PH21459A (en) Process for assaying atl virus antibody and reagent therefor
DE3273844D1 (en) Procedure for immunological determinations using two antibodies, the second antibody being purified by affinity chromatography, and supports therefor
ES8701990A1 (es) Procedimiento para la determinacion de la capacidad de fijacion de la globulina fijadora de tiroxina
EP0266686A3 (en) Latex agglutination method for the detection of an antibody against streptococcus deoxyribonuclease b
ZA869374B (en) Process and reagent for the immunological determination of testosterone and monoclonal antibodies suitable therefor
ATE122150T1 (de) Einschritt-immuntest zur bestimmung von antigen- spezifischen antikörpern aller immunglobulin- klassen und dazu geeignetes mittel.
DE3477610D1 (en) Method for the immunochemical determination of hepatitis b core antigens
EP0096520A3 (en) Antigen detection: rheumatoid arthritis
Ottó Determination of immunoglobulin subclasses by electrosyneresis
SE8705137D0 (sv) Diagnostic method for primary biliary cirrhosis and antibodies suitable to be used in certain versions of the method

Legal Events

Date Code Title Description
SA6 Expiration date (snapshot 920101)

Free format text: 2006-09-26

FD1A Patent lapsed

Effective date: 20001102